Clover Health Investments Corp [NASDAQ: CLOV] closed the trading session at $2.89 on 2025-07-07. The day’s price range saw the stock hit a low of $2.6301, while the highest price level was $2.9199.
The stocks have a year to date performance of 136.89 percent and weekly performance of 4.71 percent. The stock has been moved at -8.25 percent over the last six months. The stock has performed -6.17 percent around the most recent 30 days and changed -17.66 percent over the most recent 3-months.
If compared to the average trading volume of 7.36M shares, CLOV reached to a volume of 21641721 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Clover Health Investments Corp [CLOV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $4.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for Clover Health Investments Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 17, 2024. While these analysts kept the previous recommendation, UBS raised their target price to Neutral. The new note on the price target was released on October 07, 2024, representing the official price target for Clover Health Investments Corp stock. Previously, the target price had yet another drop from $7 to $3, while Cowen kept a Market Perform rating on CLOV stock.
CLOV stock trade performance evaluation
Clover Health Investments Corp [CLOV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.71. With this latest performance, CLOV shares dropped by -6.17% in over the last four-week period, additionally sinking by -8.25% over the last 6 months – not to mention a drop of -8.25% in the past year of trading.
Clover Health Investments Corp [CLOV]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp [CLOV] shares currently have an operating margin of -1.64%. Clover Health Investments Corp’s Net Margin is presently recorded at -1.69%.
Return on Equity for this stock declined to -3.88%, with Return on Assets sitting at -3.88%.
Clover Health Investments Corp [CLOV]: Institutional Ownership
There are presently around $26.16%, or 27.22% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: VANGUARD GROUP INC with ownership of 17.35 million shares, which is approximately 3.5581%. RENAISSANCE TECHNOLOGIES LLC, holding 11.27 million shares of the stock with an approximate value of $$13.86 million in CLOV stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$11.73 million in CLOV stock with ownership which is approximately 1.9568%.
